The National Association of Chain Drug Stores (NACDS) is providing the following statement to address questions about the House Energy and Commerce Committee’s anticipated markup of The Seniors’ Access to Critical Medications Act (H.R. 2484) and its implications for patients and their pharmacies:

“In its current form, this bill would undermine the pro-patient benefits of the pharmacist’s role in medication dispensing. It also would undermine safeguards in current law that prohibit physician self-referral within the Medicare program. We want members of Congress to know clearly that, contrary to this bill’s positioning, the legislation currently is not limited to cancer treatments. Rather, it applies broadly to all Part D drugs.

“NACDS has provided recommendations that would prevent harm to patients, to the Medicare program, to pharmacies, and to all who rely on them. NACDS looks forward to continuing to work with leaders in Congress to amend the legislation as needed. At this time, and until adequate changes are made, NACDS has no choice but to oppose the legislation.

“NACDS appreciates the leadership of Committee members to advance issues of vital importance to Americans and to their pharmacies. NACDS continues to advocate for necessary legislative priorities, and to prevent the unintended consequences of other bills as they arise.”

Share this story:

Related Posts

  • NACDS to Senate Armed Services Subcommittee: Strengthen the TRICARE Pharmacy Program Through Access, Choice, Transparency, and Accountability

    NACDS urges Congress to preserve TRICARE pharmacy oversight provisions in the Fiscal Year 2027 NDAA.

  • ICYMI: NACDS Quoted by House Ways & Means on the Main Street Pharmacy Access Act

    NACDS has long advocated for this legislation and continues to lead the case for ensuring seniors in Medicare can access the pharmacist-provided services their states already allow.

  • CMS GLP-1 Bridge Program

    NACDS continues to work closely with CMS as implementation approaches and will keep members updated as additional guidance becomes available.